skip to Main Content

Researchers Identify Five-Gene Metabolic Signature to Predict Pancreatic Cancer Patients’ Survival

Newsfeed image, light gray text on dark gray background
Researchers from Zhongshan Hospital in Shanghai have developed a five-gene signature that may better characterize pancreatic cancer patients’ survival and benefit from chemotherapy.

The research, published in Experimental Biology and Medicine earlier this month, analyzed pancreatic cancer patients’ genetic data from several databases including the National Cancer Institute’s The Cancer Genome Atlas (TCGA) and the National Center for Biotechnology Information’s Gene Expression Omnibus (GEO). Read more . . . 

Back To Top